Detalles de la búsqueda
1.
Phase 1 Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Oral Doses of DS-2969b, a Novel GyrB Inhibitor, in Healthy Subjects.
Antimicrob Agents Chemother
; 62(5)2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29439973
2.
Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours.
Br J Clin Pharmacol
; 84(1): 112-121, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28865153
3.
Evaluation of Potential Drug-Drug Interaction Risk of Pexidartinib With Substrates of Cytochrome P450 and P-Glycoprotein.
J Clin Pharmacol
; 61(3): 298-306, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32918831
4.
Validation and clinical application of dried blood spot assay for quantitative assessment of edoxaban in healthy adults.
Bioanalysis
; 12(6): 393-407, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32329378
5.
A Phase I, Single-Ascending-Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DS-2969b, a Novel GyrB Inhibitor.
J Clin Pharmacol
; 58(12): 1557-1565, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29746725
Resultados
1 -
5
de 5
1
Próxima >
>>